Optimization of Diclofenac Sodium Orodispersible Tablets with Natural Disintegrants using Response Surface Methodology
DOI:
https://doi.org/10.37285/ijpsn.2013.6.3.9Abstract
Traditionally experimental methods in the pharmaceutical formulation development involve significant amount of time and efforts to get an optimized dosage form. It is very much desirable as per industrial perspective to obtain suitable, optimized and stable formulation with minimum amount of time and effort. The purpose of this study was to study the synergic effect of natural disintegrants and central composite design in optimization of diclofenac sodium orodispersible tablets. In this study, central composite design was applied to study the effect of natural disintegrant as independent variables i.e. seed mucilage of Plantago ovata, and seed mucilage of Ocimum basilicum. Diclofenac sodium orodispersible tablets were prepared by direct compression method on Cadmech single punch machine using flat 8-mm punches and characterized for the dependent variables like disintegration time and cumulative percent drug released after 25 minutes. Optimization study by multiple regression analysis revealed that, 6% of Plantago ovata and 5% Ocimum basilicum was found to be optimum which has disintegrated in 36 secs and cumulative percent drug released was 99.2% at 25 minutes. A checkpoint formulation was prepared to prove the validity of the evolved mathematical model. These findings suggest that synergic effect of natural disintegrants of Plantago ovata and Ocimum basilicum employed with systematic experimental design approach have greater influence in optimization of diclofenac sodium orodispersible tablets. It is likely that this formulation technology can be exploited for commercial production of dispersible tablets.
Downloads
Metrics
Keywords:
Oro-dispersible tablet, natural disintegrant, plantago ovata, ocimum basilicum, Central composite design.Downloads
Published
How to Cite
Issue
Section
References
Ainley W and Paul JW (1994). Hand book of pharma-ceutical excipients.2nd ed. Royal pharmaceutical society of great Britain 483-488.
Dave BS, Amin AF and Patel MM (2004). Gastro-retentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech. 5: e34.
Kumar R, Shirwaikar AA, Shirwaikar A, Prabu SL, Mahalaxmi R, Rajendran K and Kumar CD (2007). Studies of disintegrant properties of seed mucilage of ocimum gratissimum. Ind. J. Pharm. Sci. 69: 753-758.
Mukerjee R and Wu CFJ (2006). A theory of factorial designs. New York: Springer Science Business Media, Inc. 85.
Pahwa R, Piplani M, Garg VK, Rao R and Lamba HS (2011). Formulation and evaluation of orally disintegrating tablets: comparison of natural and synthetic superdisintegrants. Der Pharmacia Lettre . 3(2): 407-18
Patro CS, Patro SS, Panda BP and Rao MEB (2011). Formulation and evaluation of Cetirizine HCl mouth fast dissolving tablets. Der Pharmacia Lettre . 3(4): 63-70.
Rao GR, Kulkarni U, Rao KD and Suresh DK (2010). Formulation and evaluation of fast dissolving tablets of carbamazepine using natural superdisintegrant plantago ovata seed powder and mucilage. Int J Pharm Pharm Sci. 2: 1-5
Rishabha M, Pranati S, Mayank B and Sharma PK (2010). Preparation and evaluation of disintegrating properties of cucurbita maxima pulp powder. Int.J.Pharm.Sci. 2(1): 395-99.
Sameer G. Late, Yi-Ying Yu and Banga A K (2009). Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Int J Pharm. 365: 4-11.
Sharma S, Sharma N andGupta GD (2010). Formulation of fast-dissolving tablets of promethazine theoclate. Tro.J.Pharm.Res. 9(5): 489-97.
Shirsand SB, Sarasija Suresh, PV Swamy, MS Para and D Nagendra Kumar (2010). Formulation design of fast disintegrating tablets using disintegrant blends. Indian J.Pharm.Sci. 72(1): 130-133.
Shirsand SB, Suresh S, Para MS, Swamy PV and Kumar DN (2009). Plantago ovata mucilage in the design of fast disintegrating tablets. Ind. J. Pharm. Sci . 71(1):41-45.
Singh B, Kumar R and Ahuja N (2005). Optimizing drug delivery systems using systematic design of experiments Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst. 22: 27-105.
Todd PA and Sorkin EM (1998). Diclofenac sodium a reappraisal of its pharmacodynamic and pharmacokinetic purpose and therapeutic efficacy. Drugs 35:244–85.